Therapeutic Cancer Vaccines: Advances, Challenges, and Future Directions
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Cancer Vaccines and Immunotherapy".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 10
Special Issue Editor
Special Issue Information
Dear Colleagues,
We welcome contributions to our upcoming Special Issue, "Therapeutic Cancer Vaccines: Advances, Challenges, and Future Directions”.
This Special Issue solicits articles that critically analyze the evolving landscape of therapeutic cancer vaccine development, focusing on solid tumors and malignant hematology. This Special Issue will explore recent research initiatives and clinical trials implementing diverse vaccination strategies. By identifying the successes and challenges within this field, this Special Issue aims to enhance our understanding of how cancer vaccines can improve treatment outcomes, whether administered alone or combined with standard of care therapy and/or immunotherapy.
This Special Issue will encompass a comprehensive overview of the current research landscape, highlighting completed and ongoing clinical trials, alongside insights from recognized experts in the field. It will detail various vaccination strategies, analyze the challenges and obstacles encountered, including issues related to efficacy and the specific patient populations that may respond favorably to vaccines, and delineate future directions to overcome these challenges within cancer vaccine development.
We welcome original research articles and review papers. Potential research areas include, but are not limited to, the following topics:
- Therapeutic vaccines in solid tumors;
- Therapeutic vaccines in malignant hematology;
- Immunotherapy and cancer vaccines;
- Cancer vaccine clinical trials.
We look forward to your valuable contributions.
Prof. Dr. Erminia Massarelli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- therapeutic cancer vaccines
- clinical trials
- solid tumors
- malignant hematology
- peptide vaccines
- DNA vaccines
- vector vaccines
- dendritic cell vaccines
- allogenic vaccines
- mRNA vaccines
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
